These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15840039

  • 1. An extremely high dose of losartan affords superior renoprotection in the remnant model.
    Fujihara CK, Velho M, Malheiros DM, Zatz R.
    Kidney Int; 2005 May; 67(5):1913-24. PubMed ID: 15840039
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney.
    Arias SC, Souza RA, Malheiros DM, Fanelli C, Fujihara CK, Zatz R.
    Am J Physiol Renal Physiol; 2016 Jan 15; 310(2):F135-43. PubMed ID: 26538442
    [Abstract] [Full Text] [Related]

  • 4. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
    Gonçalves AR, Fujihara CK, Mattar AL, Malheiros DM, Noronha Ide L, de Nucci G, Zatz R.
    Am J Physiol Renal Physiol; 2004 May 15; 286(5):F945-54. PubMed ID: 15075190
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation.
    Fanelli C, Fernandes BH, Machado FG, Okabe C, Malheiros DM, Fujihara CK, Zatz R.
    Am J Physiol Renal Physiol; 2011 Sep 15; 301(3):F580-7. PubMed ID: 21653629
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy.
    Arias SC, Valente CP, Machado FG, Fanelli C, Origassa CS, de Brito T, Camara NO, Malheiros DM, Zatz R, Fujihara CK.
    PLoS One; 2013 Sep 15; 8(2):e56215. PubMed ID: 23431367
    [Abstract] [Full Text] [Related]

  • 10. Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model.
    Fujihara CK, Antunes GR, Mattar AL, Malheiros DM, Vieira JM, Zatz R.
    Am J Physiol Renal Physiol; 2007 Jan 15; 292(1):F92-9. PubMed ID: 16896182
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec 15; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 12. Cardiorenal protection in experimental hypertension with renal failure: comparison between vasopeptidase inhibition and angiotensin receptor blockade.
    Halleck F, Schröder K, Holleck-Weithmann S, Kossmehl P, Kreutz R, Rothermund L.
    Clin Exp Hypertens; 2015 Dec 15; 37(1):26-32. PubMed ID: 24678912
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats.
    Park HW, Kim Y, Kim KH, Jeong HJ, Shin MH, Rozen S, Mauer M.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep 15; 8(3):110-7. PubMed ID: 17907098
    [Abstract] [Full Text] [Related]

  • 14. Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
    Toba H, Tojo C, Wang J, Noda K, Kobara M, Nakata T.
    Eur J Pharmacol; 2012 Jun 15; 685(1-3):91-8. PubMed ID: 22314223
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
    Álvarez-Prats A, Hernández-Perera O, Díaz-Herrera P, Ucero ÁC, Anabitarte-Prieto A, Losada-Cabrera A, Ortiz A, Rodríguez-Pérez JC.
    Nephrol Dial Transplant; 2012 Jul 15; 27(7):2720-33. PubMed ID: 22302208
    [Abstract] [Full Text] [Related]

  • 16. Effect of angiotensin II type 1 receptor blockade on conduit artery tone in subtotally nephrectomized rats.
    Kööbi P, Jolma P, Kalliovalkama J, Tikkanen I, Fan M, Kähönen M, Moilanen E, Pörsti I.
    Nephron Physiol; 2004 Jul 15; 96(3):p91-8. PubMed ID: 15056982
    [Abstract] [Full Text] [Related]

  • 17. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P, Chábová VČ, Vernerová Z, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Vaňourková Z, Husková Z, Opočenský M, Skaroupková P, Schejbalová S, Kramer HJ, Rakušan D, Malý J, Netuka I, Vaněčková I, Kopkan L, Cervenka L.
    Clin Exp Pharmacol Physiol; 2010 Dec 15; 37(12):1159-69. PubMed ID: 20880190
    [Abstract] [Full Text] [Related]

  • 18. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G.
    Kidney Int; 2009 Nov 15; 76(9):960-7. PubMed ID: 19625993
    [Abstract] [Full Text] [Related]

  • 19. Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition.
    Mattar AL, Machado FG, Fujihara CK, Malheiros DM, Zatz R.
    Clinics (Sao Paulo); 2007 Dec 15; 62(6):749-56. PubMed ID: 18209918
    [Abstract] [Full Text] [Related]

  • 20. Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination.
    Piecha G, Koleganova N, Gross ML, Geldyyev A, Adamczak M, Ritz E.
    Am J Physiol Renal Physiol; 2008 Jul 15; 295(1):F137-44. PubMed ID: 18434388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.